Tomin E. Perea-Chamblee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tomin E. Perea-Chamblee has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- James L. Manley
Columbia University
1 shared publication - Jian Zhang
Department of Biological Sciences, Columbia University, New York, NY 10027, USA
1 shared publication - Raul Rabadan
Program for Mathematical Genomics, Department of Systems Biology, Columbia University, New York, USA
1 shared publication - Yiwei Sun
Department of Systems Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, USA
1 shared publication - Zhaoqi Liu
China National Center for Bioinformation, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China
1 shared publication
Latest Publications
- 24 April 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (19) , 10305-10312
Pan-cancer analysis identifies mutations in SUGP1 that recapitulate mutant SF3B1 splicing dysregulation
Significance: SF3B1 is the most commonly mutated splicing factor in cancers, and SF3B1 mutations result in aberrant 3′ splice site usage during splicing of a subset of introns. Here, we utilized an unbiased computational biology approach to determine whether cancer-associated mutations in any other genes produce the same pattern of aberrant splicing as do SF3B1 mutations. We found that, while rare, the most frequently mutated gene that causes such splicing defects is SUGP1 . This is striking because previous biochemical studies indicated that loss of SF3B1 interaction with SUGP1 underlies the effects of SF3B1 mutations on splicing. Our findings thus establish the cancer relevance of the biochemical link between SF3B1 and SUGP1 and also identify SUGP1 as a cancer-associated gene.
- 24 April 2020
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (19) , 10305-10312
Pan-cancer analysis identifies mutations in SUGP1 that recapitulate mutant SF3B1 splicing dysregulation
Significance: SF3B1 is the most commonly mutated splicing factor in cancers, and SF3B1 mutations result in aberrant 3′ splice site usage during splicing of a subset of introns. Here, we utilized an unbiased computational biology approach to determine whether cancer-associated mutations in any other genes produce the same pattern of aberrant splicing as do SF3B1 mutations. We found that, while rare, the most frequently mutated gene that causes such splicing defects is SUGP1 . This is striking because previous biochemical studies indicated that loss of SF3B1 interaction with SUGP1 underlies the effects of SF3B1 mutations on splicing. Our findings thus establish the cancer relevance of the biochemical link between SF3B1 and SUGP1 and also identify SUGP1 as a cancer-associated gene.